# Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin

> **NCT00669695** · PHASE2 · TERMINATED · sponsor: **University Hospital, Grenoble** · enrollment: 54 (actual)

## Conditions studied

- Obstructive Sleep Apnea Syndrome

## Interventions

- **DRUG:** Atorvastatin treatment
- **OTHER:** CPAP device
- **OTHER:** sham CPAP treatment

## Key facts

- **NCT ID:** NCT00669695
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-05
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 54 (ACTUAL)
- **Why stopped:** Interim analysis performed without efficient results
- **Last updated:** 2013-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00669695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00669695, "Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00669695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*